array(40) {
  [0]=>
  string(4) "1577"
  ["article_id"]=>
  string(4) "1577"
  [1]=>
  string(49) "FDA Warns MiBo Medical for Design Controls, CAPAs"
  ["article_title"]=>
  string(49) "FDA Warns MiBo Medical for Design Controls, CAPAs"
  [2]=>
  string(153) "&#nl        Seven months after issuing a Form 483 to MiBo Medical Group following an inspection of its Dallas, Texas facility, the FDA warned the devicem"
  ["short_description"]=>
  string(153) "&#nl        Seven months after issuing a Form 483 to MiBo Medical Group following an inspection of its Dallas, Texas facility, the FDA warned the devicem"
  [3]=>
  string(275) "&#nl        Seven months after issuing a Form 483 to MiBo Medical Group following an inspection of its Dallas, Texas facility, the FDA warned the devicemaker that it had not fully addressed the problems with design control procedures, CAPA procedures or complaints.&#nl      "
  ["description"]=>
  string(275) "&#nl        Seven months after issuing a Form 483 to MiBo Medical Group following an inspection of its Dallas, Texas facility, the FDA warned the devicemaker that it had not fully addressed the problems with design control procedures, CAPA procedures or complaints.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(88) "https://www.fdanews.com/articles/189836-fda-warns-mibo-medical-for-design-controls-capas"
  ["blog_url"]=>
  string(88) "https://www.fdanews.com/articles/189836-fda-warns-mibo-medical-for-design-controls-capas"
  [15]=>
  string(19) "2019-01-12 05:53:56"
  ["add_date"]=>
  string(19) "2019-01-12 05:53:56"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:25"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1578"
  ["article_id"]=>
  string(4) "1578"
  [1]=>
  string(59) "J&J in $400 Million Settlement Over Faulty Hip Replacements"
  ["article_title"]=>
  string(59) "J&J in $400 Million Settlement Over Faulty Hip Replacements"
  [2]=>
  string(133) "&#nl        Johnson & Johnson agreed to settle consumer complaints of defective artificial hips for more than $400 million.&#nl      "
  ["short_description"]=>
  string(133) "&#nl        Johnson & Johnson agreed to settle consumer complaints of defective artificial hips for more than $400 million.&#nl      "
  [3]=>
  string(133) "&#nl        Johnson & Johnson agreed to settle consumer complaints of defective artificial hips for more than $400 million.&#nl      "
  ["description"]=>
  string(133) "&#nl        Johnson & Johnson agreed to settle consumer complaints of defective artificial hips for more than $400 million.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(97) "https://www.fdanews.com/articles/189835-jj-in-400-million-settlement-over-faulty-hip-replacements"
  ["blog_url"]=>
  string(97) "https://www.fdanews.com/articles/189835-jj-in-400-million-settlement-over-faulty-hip-replacements"
  [15]=>
  string(19) "2019-01-12 05:52:16"
  ["add_date"]=>
  string(19) "2019-01-12 05:52:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:25"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1579"
  ["article_id"]=>
  string(4) "1579"
  [1]=>
  string(62) "TGA Offers Guidance on Regulating Software as a Medical Device"
  ["article_title"]=>
  string(62) "TGA Offers Guidance on Regulating Software as a Medical Device"
  [2]=>
  string(158) "&#nl        Australia’s Therapeutic Goods Administration is reviewing how it regulates software as a medical device (SaMD) and has issued guidance on i"
  ["short_description"]=>
  string(158) "&#nl        Australia’s Therapeutic Goods Administration is reviewing how it regulates software as a medical device (SaMD) and has issued guidance on i"
  [3]=>
  string(187) "&#nl        Australia’s Therapeutic Goods Administration is reviewing how it regulates software as a medical device (SaMD) and has issued guidance on its latest thinking.&#nl      "
  ["description"]=>
  string(187) "&#nl        Australia’s Therapeutic Goods Administration is reviewing how it regulates software as a medical device (SaMD) and has issued guidance on its latest thinking.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(102) "https://www.fdanews.com/articles/189834-tga-offers-guidance-on-regulating-software-as-a-medical-device"
  ["blog_url"]=>
  string(102) "https://www.fdanews.com/articles/189834-tga-offers-guidance-on-regulating-software-as-a-medical-device"
  [15]=>
  string(19) "2019-01-12 05:50:54"
  ["add_date"]=>
  string(19) "2019-01-12 05:50:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:25"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1580"
  ["article_id"]=>
  string(4) "1580"
  [1]=>
  string(52) "FDA Issues Final Rule on Reclassification of Devices"
  ["article_title"]=>
  string(52) "FDA Issues Final Rule on Reclassification of Devices"
  [2]=>
  string(153) "&#nl        The FDA issued a final rule streamlining its classification procedures for medical devices and allowing for changing classifications by admin"
  ["short_description"]=>
  string(153) "&#nl        The FDA issued a final rule streamlining its classification procedures for medical devices and allowing for changing classifications by admin"
  [3]=>
  string(215) "&#nl        The FDA issued a final rule streamlining its classification procedures for medical devices and allowing for changing classifications by administrative orders rather than the rulemaking process.&#nl      "
  ["description"]=>
  string(215) "&#nl        The FDA issued a final rule streamlining its classification procedures for medical devices and allowing for changing classifications by administrative orders rather than the rulemaking process.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(92) "https://www.fdanews.com/articles/189833-fda-issues-final-rule-on-reclassification-of-devices"
  ["blog_url"]=>
  string(92) "https://www.fdanews.com/articles/189833-fda-issues-final-rule-on-reclassification-of-devices"
  [15]=>
  string(19) "2019-01-12 05:50:30"
  ["add_date"]=>
  string(19) "2019-01-12 05:50:30"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:25"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1523"
  ["article_id"]=>
  string(4) "1523"
  [1]=>
  string(49) "CDC: Flu Cases Hit 7 Million in the United States"
  ["article_title"]=>
  string(49) "CDC: Flu Cases Hit 7 Million in the United States"
  [2]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- The flu season is picking up steam, with about 7 million Americans having been struck by a strain of the flu virus, health of"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- The flu season is picking up steam, with about 7 million Americans having been struck by a strain of the flu virus, health of"
  [3]=>
  string(250) "FRIDAY, Jan. 11, 2019 -- The flu season is picking up steam, with about 7 million Americans having been struck by a strain of the flu virus, health officials said Friday.&#nlAlmost half of those individuals went to a doctor, while 69,000 to 84,000..."
  ["description"]=>
  string(250) "FRIDAY, Jan. 11, 2019 -- The flu season is picking up steam, with about 7 million Americans having been struck by a strain of the flu virus, health officials said Friday.&#nlAlmost half of those individuals went to a doctor, while 69,000 to 84,000..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(174) "https://www.drugs.com/news/cdc-flu-cases-hit-7-million-united-states-79695.html?utm_source=ddc&utm_medium=rss&utm_campaign=CDC%3A+Flu+Cases+Hit+7+Million+in+the+United+States"
  ["blog_url"]=>
  string(174) "https://www.drugs.com/news/cdc-flu-cases-hit-7-million-united-states-79695.html?utm_source=ddc&utm_medium=rss&utm_campaign=CDC%3A+Flu+Cases+Hit+7+Million+in+the+United+States"
  [15]=>
  string(19) "2019-01-12 03:00:42"
  ["add_date"]=>
  string(19) "2019-01-12 03:00:42"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1524"
  ["article_id"]=>
  string(4) "1524"
  [1]=>
  string(63) "About Half of Young Patients Have Had Private Time With Doctors"
  ["article_title"]=>
  string(63) "About Half of Young Patients Have Had Private Time With Doctors"
  [2]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- About half of adolescent and young adult (AYA) patients report having had private time with a health care provider (HCP) and "
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- About half of adolescent and young adult (AYA) patients report having had private time with a health care provider (HCP) and "
  [3]=>
  string(251) "FRIDAY, Jan. 11, 2019 -- About half of adolescent and young adult (AYA) patients report having had private time with a health care provider (HCP) and having spoken to an HCP about confidentiality, according to a study published online Jan. 9 in the..."
  ["description"]=>
  string(251) "FRIDAY, Jan. 11, 2019 -- About half of adolescent and young adult (AYA) patients report having had private time with a health care provider (HCP) and having spoken to an HCP about confidentiality, according to a study published online Jan. 9 in the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(189) "https://www.drugs.com/news/young-patients-have-had-private-time-doctors-79693.html?utm_source=ddc&utm_medium=rss&utm_campaign=About+Half+of+Young+Patients+Have+Had+Private+Time+With+Doctors"
  ["blog_url"]=>
  string(189) "https://www.drugs.com/news/young-patients-have-had-private-time-doctors-79693.html?utm_source=ddc&utm_medium=rss&utm_campaign=About+Half+of+Young+Patients+Have+Had+Private+Time+With+Doctors"
  [15]=>
  string(19) "2019-01-12 03:00:12"
  ["add_date"]=>
  string(19) "2019-01-12 03:00:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1507"
  ["article_id"]=>
  string(4) "1507"
  [1]=>
  string(41) "Make Cancer Prevention a Priority in 2019"
  ["article_title"]=>
  string(41) "Make Cancer Prevention a Priority in 2019"
  [2]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- If one of your resolutions for 2019 is to improve your health, reducing your risk of cancer should be part of that goal, a ca"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 11, 2019 -- If one of your resolutions for 2019 is to improve your health, reducing your risk of cancer should be part of that goal, a ca"
  [3]=>
  string(257) "FRIDAY, Jan. 11, 2019 -- If one of your resolutions for 2019 is to improve your health, reducing your risk of cancer should be part of that goal, a cancer expert says.&#nlWhile cancer risk factors such as family history and aging can't be controlled,..."
  ["description"]=>
  string(257) "FRIDAY, Jan. 11, 2019 -- If one of your resolutions for 2019 is to improve your health, reducing your risk of cancer should be part of that goal, a cancer expert says.&#nlWhile cancer risk factors such as family history and aging can't be controlled,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(159) "https://www.drugs.com/news/make-cancer-prevention-priority-2019-79690.html?utm_source=ddc&utm_medium=rss&utm_campaign=Make+Cancer+Prevention+a+Priority+in+2019"
  ["blog_url"]=>
  string(159) "https://www.drugs.com/news/make-cancer-prevention-priority-2019-79690.html?utm_source=ddc&utm_medium=rss&utm_campaign=Make+Cancer+Prevention+a+Priority+in+2019"
  [15]=>
  string(19) "2019-01-12 01:01:07"
  ["add_date"]=>
  string(19) "2019-01-12 01:01:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1542"
  ["article_id"]=>
  string(4) "1542"
  [1]=>
  string(118) "UK needs far greater investment into diabetes research, Diabetes UK head of research says at RPS/UCL New Year lecture "
  ["article_title"]=>
  string(118) "UK needs far greater investment into diabetes research, Diabetes UK head of research says at RPS/UCL New Year lecture "
  [2]=>
  string(137) "The UK is a world leader in diabetes research, but urgently needs greater investment to translate that innovation into clinical practice."
  ["short_description"]=>
  string(137) "The UK is a world leader in diabetes research, but urgently needs greater investment to translate that innovation into clinical practice."
  [3]=>
  string(137) "The UK is a world leader in diabetes research, but urgently needs greater investment to translate that innovation into clinical practice."
  ["description"]=>
  string(137) "The UK is a world leader in diabetes research, but urgently needs greater investment to translate that innovation into clinical practice."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(196) "https://www.pharmaceutical-journal.com/news-and-analysis/event/uk-needs-far-greater-investment-into-diabetes-research-diabetes-uk-head-of-research-says-at-rps/ucl-new-year-lecture/20205991.article"
  ["blog_url"]=>
  string(196) "https://www.pharmaceutical-journal.com/news-and-analysis/event/uk-needs-far-greater-investment-into-diabetes-research-diabetes-uk-head-of-research-says-at-rps/ucl-new-year-lecture/20205991.article"
  [15]=>
  string(19) "2019-01-12 00:19:00"
  ["add_date"]=>
  string(19) "2019-01-12 00:19:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1543"
  ["article_id"]=>
  string(4) "1543"
  [1]=>
  string(94) "London to end minor ailments service with replacement solely for 'vulnerable' patients"
  ["article_title"]=>
  string(94) "London to end minor ailments service with replacement solely for 'vulnerable' patients"
  [2]=>
  string(152) "Exclusive: A community pharmacy-run minor ailments service exclusively for people who are “socially vulnerable” is being planned for London."
  ["short_description"]=>
  string(152) "Exclusive: A community pharmacy-run minor ailments service exclusively for people who are “socially vulnerable” is being planned for London."
  [3]=>
  string(152) "Exclusive: A community pharmacy-run minor ailments service exclusively for people who are “socially vulnerable” is being planned for London."
  ["description"]=>
  string(152) "Exclusive: A community pharmacy-run minor ailments service exclusively for people who are “socially vulnerable” is being planned for London."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(163) "https://www.pharmaceutical-journal.com/news-and-analysis/news/london-to-end-minor-ailments-service-with-replacement-solely-for-vulnerable-patients/20205996.article"
  ["blog_url"]=>
  string(163) "https://www.pharmaceutical-journal.com/news-and-analysis/news/london-to-end-minor-ailments-service-with-replacement-solely-for-vulnerable-patients/20205996.article"
  [15]=>
  string(19) "2019-01-11 23:29:00"
  ["add_date"]=>
  string(19) "2019-01-11 23:29:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1544"
  ["article_id"]=>
  string(4) "1544"
  [1]=>
  string(74) "Nine out of ten patients rate minor ailments scheme as 'excellent'"
  ["article_title"]=>
  string(74) "Nine out of ten patients rate minor ailments scheme as 'excellent'"
  [2]=>
  string(150) "The community pharmacy-run minor ailments scheme in Scotland has been an overwhelming success, according to independent research which, for the first "
  ["short_description"]=>
  string(150) "The community pharmacy-run minor ailments scheme in Scotland has been an overwhelming success, according to independent research which, for the first "
  [3]=>
  string(196) "The community pharmacy-run minor ailments scheme in Scotland has been an overwhelming success, according to independent research which, for the first time, sought the views of patients who use it."
  ["description"]=>
  string(196) "The community pharmacy-run minor ailments scheme in Scotland has been an overwhelming success, according to independent research which, for the first time, sought the views of patients who use it."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(143) "https://www.pharmaceutical-journal.com/news-and-analysis/news/nine-out-of-ten-patients-rate-minor-ailments-scheme-as-excellent/20205988.article"
  ["blog_url"]=>
  string(143) "https://www.pharmaceutical-journal.com/news-and-analysis/news/nine-out-of-ten-patients-rate-minor-ailments-scheme-as-excellent/20205988.article"
  [15]=>
  string(19) "2019-01-11 22:59:00"
  ["add_date"]=>
  string(19) "2019-01-11 22:59:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1545"
  ["article_id"]=>
  string(4) "1545"
  [1]=>
  string(60) "NICE rejects 'promising' new treatment for migraine "
  ["article_title"]=>
  string(60) "NICE rejects 'promising' new treatment for migraine "
  [2]=>
  string(152) "The first monoclonal antibody therapy for migraine prevention has not been recommended by the National Institute for Health and Care Excellence on th"
  ["short_description"]=>
  string(152) "The first monoclonal antibody therapy for migraine prevention has not been recommended by the National Institute for Health and Care Excellence on th"
  [3]=>
  string(192) "The first monoclonal antibody therapy for migraine prevention has not been recommended by the National Institute for Health and Care Excellence on the grounds that it is not cost effective."
  ["description"]=>
  string(192) "The first monoclonal antibody therapy for migraine prevention has not been recommended by the National Institute for Health and Care Excellence on the grounds that it is not cost effective."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(137) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/nice-rejects-promising-new-treatment-for-migraine/20205986.article"
  ["blog_url"]=>
  string(137) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/nice-rejects-promising-new-treatment-for-migraine/20205986.article"
  [15]=>
  string(19) "2019-01-11 22:13:00"
  ["add_date"]=>
  string(19) "2019-01-11 22:13:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1546"
  ["article_id"]=>
  string(4) "1546"
  [1]=>
  string(53) "How the pregabalin case has set back drug repurposing"
  ["article_title"]=>
  string(53) "How the pregabalin case has set back drug repurposing"
  [2]=>
  string(155) "The 2018 Supreme Court verdict on Pfizer’s second medical use patent for Lyrica has drawn attention to the limitations of the current framework for "
  ["short_description"]=>
  string(155) "The 2018 Supreme Court verdict on Pfizer’s second medical use patent for Lyrica has drawn attention to the limitations of the current framework for "
  [3]=>
  string(203) "The 2018 Supreme Court verdict on Pfizer’s second medical use patent for Lyrica has drawn attention to the limitations of the current framework for extending the usefulness of existing treatments."
  ["description"]=>
  string(203) "The 2018 Supreme Court verdict on Pfizer’s second medical use patent for Lyrica has drawn attention to the limitations of the current framework for extending the usefulness of existing treatments."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(136) "https://www.pharmaceutical-journal.com/news-and-analysis/features/how-the-pregabalin-case-has-set-back-drug-repurposing/20205970.article"
  ["blog_url"]=>
  string(136) "https://www.pharmaceutical-journal.com/news-and-analysis/features/how-the-pregabalin-case-has-set-back-drug-repurposing/20205970.article"
  [15]=>
  string(19) "2019-01-11 22:10:00"
  ["add_date"]=>
  string(19) "2019-01-11 22:10:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}